相关实验视频

Updated: Mar 15, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

儿科癌症结构变化的景观

Robert Greenhalgh¹, Samuel W Brady², Wentao Yang¹

¹Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

|March 13, 2026

概括

结构变异 (SVs) 导致超过60%的儿科癌症. 这项研究表明,儿童的SV负担低于成人固体瘤,但在血液癌症中相当,这意味着RAG介导的突变发生.

科学领域:

基因组学就是基因组学.
癌症生物学癌症生物学
分子瘤学分子瘤学

背景情况:

结构变异 (SV) 是儿科癌症的主要驱动因素,占驱动变异的60%以上.
了解儿科和成人癌症中SVs的风景和机制对于向治疗至关重要.

研究的目的:

为了比较儿科和成人癌症结构变异的负担和特征.
调查RAG介导的突变发生在儿科淋巴细胞恶性瘤中的作用.
探索SVs对瘤内异质性的进化影响.

主要方法:

从1,616名儿科和2,203名成人癌症患者的全基因组测序数据的泛癌症分析.
结构变体特征的识别和表征.
来自具有明显时间和空间疾病特征的患者样本的集群分析.

主要成果:

儿童的SV负担在不同类型的癌症中存在显著差异,通常低于成人固体瘤,但在血液恶性瘤中可比较.
在儿科癌症中,顶级SV破坏基因充当驱动因素,而在成人癌症中,它们代表脆弱的部位.
在RAG重组信号序列附近的复发性SV热点破坏了儿科急性淋巴细胞白血病的免疫位点和驱动基因,这表明RAG介导的突变作为COSMIC SV7的病因.

结论:

结构变异在儿科癌症的发展中起着重要作用,与成人癌症相比,其有着不同的模式.
RAG介导的突变发生与某些儿科淋巴细胞癌症的病因有关.
该研究提供了有价值的SV数据集和对SV演变的见解,有助于未来的研究和临床应用.

关键词:

通过RAG介导的重组组合.癌症的演化癌症的演化癌症基因组学癌症基因组学儿科癌症儿科癌症这是资源资源.签名签名签名结构变化的结构变化.

更多相关视频

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...